NATR · NASDAQ · Packaged Foods

Nature's Sunshine Products (NATR)

Manufactures herbal nutrition and personal care products through a global direct-selling network.

$13.22
vs last close+0.20 (+1.56%)
Loading prices…

Nature's Sunshine Products, Inc.NATR
Consumer Staples

Manufactures and directly sells nutritional and personal care products through independent consultants under the Nature's Sunshine Products and Synergy WorldWide brands. The business is organized by geography, with sales weighted outside the United States and operating exposure to direct-selling rules, product regulation, local currencies, and China/Hong Kong ownership.

Manufactures and directly sells nutritional and personal care products under the Nature's Sunshine Products and Synergy WorldWide brands, with categories spanning general health, digestive, cardiovascular, immune, personal care, and weight management. Most products are made in Spanish Fork, Utah after bulk herbs and raw materials go through quality-control testing.

Organized by Asia, Europe, North America, and Latin America and Other, the business is more international than domestic, with the United States, Taiwan, Japan, and South Korea each material to sales. Independent consultants buy products for personal use or resale, and compensation is tied to product sales through their organizations.

Direct-selling rules, consultant conduct, dietary-supplement regulation, local-currency exposure, and direct ownership in China and Hong Kong shape the operating model.

Company facts

CEOKenneth Romanzi
ListedJun 25, 2009
ExchangeNASDAQ
HeadquartersLehi, UT
CountryUnited States
Employees806
CIK0000275053
ISINUS6390271012

Market cap$229.0M
EPS (ttm)$1.01
P/E (ttm)12.89
ROE11.0%
P/B1.35
P/S0.4653
Dividend yieldDiv yield
Beta0.40vs XLP 0.88

Price target$31.00+138.1%Average of 4 analysts
ConsensusBuy2 of 4 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 10, 2026DA DavidsonReiterate
Rating: Target: $21
Rating: BuyTarget: $25
May 8, 2026Canaccord GenuityTarget
Target: $18
Target: $37
Oct 21, 2025D.A. DavidsonTarget
Target:
Target: $21

Next report
Nov 9, 26
estimated · in 48 days
EPS estimate
$0.27
Revenue estimate
$129.5M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Jul '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.02$0.25$0.35$0.36$0.30$0.30$0.21Pending
Estimate$0.20$0.17$0.18$0.19$0.19$0.21$0.27$0.27
Surprise−110.0%+47.1%+94.4%+89.5%+62.2%+46.3%−22.2%

RevenueReportedEstimate

Mar '25May '25Jul '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$118.2M$113.2M$114.8M$128.3M$123.8M$122.9M$117.0MPending
Estimate$109.3M$114.4M$119.4M$121.6M$121.5M$122.2M$123.7M$129.5M
Surprise+8.1%−1.0%−3.9%+5.5%+1.9%+0.6%−5.4%
Estimate$0.27
ReportedDue Nov 9, 2026
Estimate$129.5M
ReportedDue Nov 9, 2026
View details

Debt to equity12.70%
Current ratio259.50%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$114.6M$118.2M$113.2M$114.8M$128.3M$123.8M$122.9M$117.0M
Net income$4.3M−$321.0K$4.7M$5.3M$5.3M$4.1M$5.1M$3.5M
Net margin3.8%0.0%4.2%4.6%4.2%3.3%4.2%3.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$5.3M$4.6M$6.2M$4.3M$9.0M$5.3M$9.5M$5.5M
YoY growth−9.4%−20.3%+33.5%−24.2%+69.9%+17.0%+54.7%+28.2%

Balance sheet, Jun 30, 2026Cash & short-term investments $82.5M · Total debt $21.4M · Total assets $259.8M · Shareholders' equity $169.3M

Revenue
$117.0M
Operating income
$5.5M
Net income
$3.5M
View details

No dividends on record.

Institutions≈ 89.65%15.78M shares
154 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders8.84%1.56M shares
20 holders · as of Sep 15, 2026
Strategic holders16.22%2.85M shares
1 holder · as of Jun 9, 2025
Adds to114.71%

17.60M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 114.71%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Fosun Pharma USA Inc.Strategic10 percent owner
16.22%2.85Mfiled Jun 9, 2025
Wynnefield Capital IncInstitution
14.06%2.47Mas of Jun 30, 2026
Prescott Group Capital Management, L.L.C.Institution
10.13%1.78Mas of Jun 30, 2026
Paradigm Capital Management, Inc.Institution
6.54%1.15Mfiled Feb 10, 2021
The Vanguard GroupInstitution
5.87%1.03Mfiled Feb 10, 2022

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 17, 2026Prescott Group Capital Management, L.L.C.10 percent owner+20,000$14.69
Aug 10, 2026Prescott Group Capital Management, L.L.C.10 percent owner+40,876$15.84
Aug 7, 2026Prescott Group Capital Management, L.L.C.10 percent owner+96,000$16.63
Aug 6, 2026Prescott Group Capital Management, L.L.C.10 percent owner+4,513$16.57
Jun 12, 2026Kevin R. Herbertofficer: EVP & President, North America−2,000$20.68
View details

  • USANA Health Sciences

    Direct-selling nutrition and personal care across similar wellness markets

  • Herbalife

    Direct-selling nutrition peer with weight-management overlap

  • Nu Skin

    Affiliate-led beauty and wellness peer with Asia exposure

  • LifeVantage

    Smaller direct-selling wellness peer with supplement overlap

Compare

CompanyPriceChange
Nature's Sunshine Products$13.22+1.56%$229.0M12.912.30.5+2.0%
USANA Health Sciences$14.74+1.73%$267.5M14.50.3−5.3%
Herbalife$12.18+2.18%$1.24B7.74.60.2+5.4%
Nu Skin$4.85+3.53%$227.2M5.00.2−17.1%
LifeVantage$6.20−0.32%$78.5M15.521.40.4−23.1%
Median11.69.70.3−11.2%